CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 9,200 shares at $3.41 ($31,350)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $3.15 ($31,499)
- 4 Open-market buy President and CEO bought 15,000 shares at $3.14 ($47,100)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.54 ($17,700)
- 4 Open-market buy President and CEO bought 20,000 shares at $3.54 ($70,790)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,188 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 11,632 shares (to pay taxes)
- 4 Grant or award Chief Business Officer acquired 4,571 shares (grant or award)
- 4 Shares withheld for taxes Chief Business Officer gave up 4,229 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 17,898 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 4,748 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 3,855 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 17,984 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 4,373 shares (to pay taxes)
Page 2 of 34 · 674 filings